This analysis revealed that AFAP1L1 protein phosphorylation levels were significantly altered at seven sites (S747, S745, S329, S98, S712, S296, and S714) in six types of cancer, including GBM (Additional file 2: Fig. S2A–D), LUAD (Additional file 2: Fig. S2E–G), HCC (Additional file 2: Fig. S2H–J), ovarian cancer (Additional file 2: Fig. S2K–M), clear cell RCC (Additional file 2: Fig. S2N–Q), and PAAD (Additional file 2: Fig. S2R–T). This evidence concerns the gene AFAP1L1 and glioblastoma.